Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001554795-13-000478
Filing Date
2013-08-14
Accepted
2013-08-14 17:55:28
Documents
9
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q irsb063013form10q.htm 10-Q 320254
2 EXHIBIT 31.1 irsb063013exh311.htm EX-31.1 10554
3 EXHIBIT 32.1 irsb063013exh321.htm EX-32.1 4739
  Complete submission text file 0001554795-13-000478.txt   3860927

Data Files

Seq Description Document Type Size
4 XBRL PRESENTATION FILE irsb-20130630_pre.xml EX-101.PRE 139700
5 XBRL LABEL FILE irsb-20130630_lab.xml EX-101.LAB 201196
6 XBRL DEFINITION FILE irsb-20130630_def.xml EX-101.DEF 40486
7 XBRL CALCULATION FILE irsb-20130630_cal.xml EX-101.CAL 27007
8 XBRL SCHEMA FILE irsb-20130630.xsd EX-101.SCH 31957
9 XBRL INSTANCE FILE irsb-20130630.xml EX-101.INS 305921
Mailing Address 5201 GREAT AMERICA PARKWAY SUITE 320 SANTA CLARA CA 95054
Business Address 5201 GREAT AMERICA PARKWAY SUITE 320 SANTA CLARA CA 95054 408 867 2885
IRIS BIOTECHNOLOGIES INC (Filer) CIK: 0001396238 (see all company filings)

EIN.: 770506396 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53245 | Film No.: 131039311
SIC: 3841 Surgical & Medical Instruments & Apparatus